677 Phase II trial assessing safety, efficacy and immune correlates of heterologous prime-boost with pBI-11 (IM) and TA-HPV (IM) plus pembrolizumab for advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal cancer

677 Phase II trial assessing safety, efficacy and immune correlates of heterologous prime-boost with pBI-11 (IM) and TA-HPV (IM) plus pembrolizumab for advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal cancer

Bibliographic Details
Main Authors:	Tc Wu, Francis Worden, Michael K Gibson, Panayiotis Savvides, Ellen Heimann-Nichols, Richard Roden, Yung-Nien Chang
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Longitudinal analysis on the ecological dynamics of the cervicovaginal microbiome in hrHPV infection
by: Mariano A. Molina, et al.
Published: (2023-01-01)

hrHPV E5 oncoprotein: immune evasion and related immunotherapies
by: Antonio Carlos de Freitas, et al.
Published: (2017-05-01)

Assessing the Cervicovaginal Microbiota in the Context of hrHPV Infections: Temporal Dynamics and Therapeutic Strategies
by: Mariano A. Molina, et al.
Published: (2022-10-01)

High-risk human papillomavirus (hrHPV) prevalence and genotype distribution among turkish women
by: Melin Gecer
Published: (2023-01-01)

Evaluation of the impacts of photodynamic therapy on the prognosis of patients with hrHPV infection based on BTNL8 expression
by: Hongqing Lv, et al.
Published: (2023-06-01)

In-depth insights into cervicovaginal microbial communities and hrHPV infections using high-resolution microbiome profiling
by: Mariano A. Molina, et al.
Published: (2022-09-01)

Performance of Human Gene EPB41L3 and HPV 16/18 Viral DNA Methylation to Triage hrHPV-Positive Women
by: Remila Rezhake, et al.
Published: (2023-12-01)

Vaginal dysbiosis seems associated with hrHPV infection in women attending the Dutch Cervical Cancer Screening Program
by: Anne J. M. Loonen, et al.
Published: (2024-03-01)

A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results
by: Yi Zhang, et al.
Published: (2023-11-01)

Efficacy in Treatment of Cervical HrHPV Infection by Combination of Beta Interferon, and Herbal Therapy in Woman with Different Cervical Lesions
by: Ermina Iljazović, et al.
Published: (2008-11-01)

The distribution of hrHPV genotypes among cervical cancer cases diagnosed across Ghana: a cross-sectional study
by: Patrick Kafui Akakpo, et al.
Published: (2024-03-01)

hrHPV prevalence and type distribution in rural Zimbabwe: A community-based self-collection study using near-point-of-care GeneXpert HPV testing
by: Megan B. Fitzpatrick, et al.
Published: (2019-05-01)

Targeted RNA next generation sequencing analysis of cervical smears can predict the presence of hrHPV-induced cervical lesions
by: Karolina M. Andralojc, et al.
Published: (2022-06-01)

HPV Genotype Specific and Age Stratified Immediate Prevalence of Cervical Precancers and Cancers in Women with NILM/hrHPV+: A Single Center Retrospective Study of 26,228 Cases
by: Liu Q, et al.
Published: (2021-09-01)

Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease
by: Iris Babion, et al.
Published: (2019-06-01)

PAX1 and SEPT9 methylation analyses in cervical exfoliated cells are highly efficient for detecting cervical (pre)cancer in hrHPV-positive women
by: Lulu He, et al.
Published: (2023-12-01)

Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme
by: J. de Waard, et al.
Published: (2023-06-01)

Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer
by: Marcus Wurlitzer, et al.
Published: (2020-06-01)

Sensitive HPV detection in oropharyngeal cancers
by: Winder, D.M., et al.
Published: (2009)

Sensitive HPV detection in oropharyngeal cancers
by: Stanley Margaret A, et al.
Published: (2009-12-01)

sHPV-mediated oropharyngeal carcinogenesis: An overview
by: Shankargouda Patil
Published: (2022-01-01)

The Effect of Prophylactic HPV Vaccines on Oral and Oropharyngeal HPV Infection—A Systematic Review
by: Kristoffer Juul Nielsen, et al.
Published: (2021-07-01)

Oral health in HPV-positive and HPV-negative patients with oropharyngeal squamous cell carcinoma
by: Philipp Kanzow, et al.
Published: (2023-01-01)

Using radiomics for predicting the HPV status of oropharyngeal tumors
by: Kubra Sarac, et al.
Published: (2024-01-01)

Molecular pathways in the development of HPV-induced oropharyngeal cancer
by: Muhammad Ikram Ullah, et al.
Published: (2023-12-01)

Surgical clinical trials for HPV-positive oropharyngeal carcinoma
by: Chen Lin, et al.
Published: (2022-11-01)

Current perspectives on recurrent HPV-mediated oropharyngeal cancer
by: Theresa Guo, et al.
Published: (2022-08-01)

Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas
by: Ge Gao, et al.
Published: (2019-04-01)

Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years
by: Linnea Haeggblom, et al.
Published: (2017-12-01)

ART is key to clearing oncogenic HPV genotypes (HR-HPV) in anal mucosa of HIV-positive MSM.
by: Carmen Hidalgo-Tenorio, et al.
Published: (2019-01-01)

Comparison of Selected Immune and Hematological Parameters and Their Impact on Survival in Patients with HPV-Related and HPV-Unrelated Oropharyngeal Cancer
by: Adam Brewczyński, et al.
Published: (2021-06-01)

Determinants of the level of circulating-tumor HPV16 DNA in patients with HPV-associated oropharyngeal cancer at the time of diagnosis
by: Marek Kentnowski, et al.
Published: (2023-12-01)

The Role of HPV and Non-HPV Sexually Transmitted Infections in Patients with Oropharyngeal Carcinoma: A Case Control Study
by: Barbara Kofler, et al.
Published: (2020-05-01)

Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer
by: Isis de Araújo Ferreira Muniz, et al.
Published: (2024-04-01)

Diagnostic Delay in HPV-Related Oropharyngeal Squamous Cell Carcinoma
by: Patrick O. McGarey, et al.
Published: (2024-01-01)

HPV16 Impacts NHERF2 Expression in Oropharyngeal Cancers
by: Lucija Lulić, et al.
Published: (2023-08-01)

Low Prevalence of HPV Related Oropharyngeal Carcinogenesis in Northern Sardinia
by: Francesco Bussu, et al.
Published: (2022-08-01)

Impact of Alcohol and Smoking on Outcomes of HPV-Related Oropharyngeal Cancer
by: Yu-Hsuan Lai, et al.
Published: (2022-11-01)

Parental perceptions of the HPV vaccine for prevention of anogenital and oropharyngeal cancers
by: Beth I. Schwartz, et al.
Published: (2023-08-01)

Influence of sex on survival rates of HPV-positive oropharyngeal cancers
by: Sally H. Preissner, et al.
Published: (2022-08-01)